Clinical experience with SonoVue in myocardial perfusion imaging

Echocardiography

Volumn 17, Issue 6 II, 2000, Pages s17-s23

  Rovai, D ^a   Morales, M A ^a   Amyot, R ^a   L'Abbate, A ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Contrast agents; Echocardiography; Imaging; Myocardial perfusion

Indexed keywords

CONTRAST MEDIUM; SONOVUE;

CARDIOVASCULAR DISEASE; COLLATERAL CIRCULATION; CONFERENCE PAPER; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; CORONARY ARTERY BLOOD FLOW; DEVICE; DIAGNOSTIC IMAGING; EXPERIENCE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0033793188     PISSN: 07422822     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2000.tb01190.x     Document Type: Conference Paper

References (41)

1. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: Identification of myocardial risk area and infarct size in the canine model of ischemia
2. Myocardial contrast echocardiography in experimental coronary artery occlusion with a new intravenously administered contrast agent
3. Detection of perfusion defects during coronary occlusion and myocardial reperfusion after thrombolysis by intravenous administration of the echo-enhancing agent BR1
4. Serial contrast echocardiography using intravenous NC100100 can detect a reduction of initial myocardial contrast defect in first myocardial infarction treated with primary PTCA
5. Myocardial perfusion abnormalities by intravenous administration of the contrast agent NC100100 in an experimental model of coronary artery thrombosis and reperfusion
6. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction
7. Prediction of short- and intermediate-term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization
8. The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of thrombolysis in myocardial infarction (TIMI) 3 flow in patients with acute myocardial infarction
9. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography
10. Comparison of myocardial contrast echocardiogrphy and low-dose dobutamine stress echocardiography in predicting recovery of left ventriculare function after coronary revascularization in chronic ischemic heart disease
11. Myocardial contrast echocardiography versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary coronary angioplasty
12. Identification of hibernating myocardium: Comparative accuracy of myocardial contrast echocardiography, rest-redistribution thallium-201 tomography and dobutamine echocardiography
13. Early changes in myocardial perfusion patterns after myocardial infarction: Relation with contractile reserve and functional recovery
14. Acute assessment of microvascular perfusion patterns by myocardial contrast echocardiography during myocardial infarction: Relation to timing and extent of functional recovery
15. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin
16. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
17. Safety and efficacy of a new transpulmonary contrast agent: Initial multicenter clinical results
18. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: Results of a phase III multicenter trial
19. BR1: A new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles
20. Characteristics of SonoVue
21. Clinical Pharmacology of BR 1, a new stabilized, bubble-based echocontrast agent
22. Clinical safety evaluation of BR1 a new stabilized bubble-based echocontrast agent: Phase I results
23. Linear dose response relationship with the US contrast agent BR1: A quantitative study in normal volunteers
24. Safety and ultrasound-enhancing potentials of a new sulfur hexafluoride-containing agent in the cerebral circulation
25. A Phase I evaluation of the safety of higher doses of SonoVue during ultrasound imaging in normal subjects
26. Human pharmakokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging
27. Power Doppler contrast echocardiography - A new technique for the assessment of myocardial perfusion
28. Assessment of resting perfusion with myocardial contrast echocardiography: Theoretical and practical
29. Assessment of resting myocardial perfusion using SonoVue myocardial contrast echocardiography using triggered pulse inversion harmonic imaging: A comparison to SPECT sestamibi imaging
30. Quantitation of echocontrast effects
31. Quantification of myocardial perfusion with myocardial contrast echocardiography during left atrial injection of contrast: Implications for venous injection
32. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant intravenous infusion
33. Anisotropy of the ultrasonic backscatter of myocardial tissue I. Theory and measurements in vitro
34. Anisotropy of the ultrasonic backscatter of myocardial tissue II. Theory and measurements in vivo
35. Acoustically stimulated transient power scattering explains enhanced detection of the very low velocities in myocardial capillaries by power Doppler imaging: An in vitro study
36. Pulse inversion Doppler. A new method for detecting nonlinear echoes from microbubble contrast agents
37. Perfusion imaging with pulse inversion Doppler and microbubble contrast agents: In vivo studies of the myocardium
38. Equations for measuring blood flow by external measurement of radioisotopes
39. Successful and reproducible myocardial opacification during two-dimensional echocardiography from right heart injection of contrast
40. Increased ultrasound contrast and decreased microbubble destruction rates using triggered ultrasound imaging
41. Myocardial contrast echo effect: The dilemma of coronary blood flow and volume